Posted By
Deep Shah
13-Aug-2019 17:09
Found In
Egroup:
Boston Chapter
\
view thread
Dear Regulatory Community - I was hoping that someone here can provide me some insight from their experience with SEND data sets for non-clinical studies. As per the guidance "Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, ...
|